Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Aprepitant × Clear all

Sponsor

Conditions

Vomiting 14 Nausea 13 Ovarian Neoplasms 4 Neoplasms 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Breast Neoplasms 4 Sezary Syndrome 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Testicular Neoplasms 2 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Myeloproliferative Disorders 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Neutrophilic, Chronic 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Accelerated Phase 2

Interventions

blinatumomab 6 Rituximab 4 Cyclophosphamide 4 Tacrolimus 3 ponatinib 2 fludarabine 2 denileukin diftitox 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Cytarabine 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 Alemtuzumab 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibrutinib 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡